{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:09:13Z","timestamp":1761718153826},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00277-010-1063-5","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T08:22:36Z","timestamp":1283847756000},"page":"611-612","source":"Crossref","is-referenced-by-count":16,"title":["Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia"],"prefix":"10.1007","volume":"90","author":[{"given":"Philip","family":"Fodstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Dheyauldeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Rinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Bachmann-Harildstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,8]]},"reference":[{"issue":"9","key":"1063_CR1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00277-006-0147-8","volume":"85","author":"D Flieger","year":"2006","unstructured":"Flieger D, Hainke S, Fischbach W (2006) Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Ann Hematol 85(9):631\u2013632","journal-title":"Ann Hematol"},{"issue":"20","key":"1063_CR2","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMc0901421","volume":"360","author":"P Bose","year":"2009","unstructured":"Bose P, Holter JL, Selby GB (2009) Bevacizumab in hereditary hemorrhagic telangiectasia. N Engl J Med 360(20):2143\u20132144","journal-title":"N Engl J Med"},{"issue":"1","key":"1063_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/194589240602000116","volume":"20","author":"EJ Mahoney","year":"2006","unstructured":"Mahoney EJ, Shapshay SM (2006) New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Am J Rhinol 20(1):87\u201390","journal-title":"Am J Rhinol"},{"issue":"4","key":"1063_CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00005537-200404000-00021","volume":"114","author":"JJ Jameson","year":"2004","unstructured":"Jameson JJ, Cave DR (2004) Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 114(4):705\u2013709","journal-title":"Laryngoscope"},{"issue":"2","key":"1063_CR5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/lary.20065","volume":"119","author":"E Yaniv","year":"2009","unstructured":"Yaniv E, Preis M, Hadar T, Shvero J, Haddad M (2009) Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Laryngoscope 119(2):284\u2013288","journal-title":"Laryngoscope"},{"issue":"2","key":"1063_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/lt.21417","volume":"14","author":"A Mitchell","year":"2008","unstructured":"Mitchell A, Adams LA, Macquillan G, Tibballs J, vanden Driesen R, Delriviere L (2008) Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl 14(2):210\u2013213","journal-title":"Liver Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00277-010-1063-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:20:44Z","timestamp":1559607644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1063-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,8]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1063-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,8]]}}}